{"disease":{"id":"angelman-syndrome","name":"angelman syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT05293184","title":"The Global Angelman Syndrome Registry","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Foundation for Angelman Syndrome Therapeutics, Australia","has_results":false},{"nct_id":"NCT04768803","title":"Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and/or Overweight, and/or Obesity","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"University Hospital, Toulouse","has_results":false},{"nct_id":"NCT03358823","title":"Study on the Brain Network of Angelman Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT03882918","title":"An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":141,"lead_sponsor_name":"Healx AI","has_results":true},{"nct_id":"NCT06353620","title":"Structural-functional Connectome in Drug-resistant Epilepsies and Neurodevelopmental Syndromes With Epilepsy","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"IRCCS Eugenio Medea","has_results":false},{"nct_id":"NCT03836300","title":"Parent and Infant Inter(X)Action Intervention (PIXI)","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":120,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT04106557","title":"A Study of OV101 in Individuals With Angelman Syndrome (AS)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":104,"lead_sponsor_name":"Healx AI","has_results":true},{"nct_id":"NCT03650569","title":"Italian Angelman Syndrome Registry","phase":"","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS","has_results":false},{"nct_id":"NCT04428281","title":"A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7248824 in Participants With Angelman Syndrome (AS)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT04259281","title":"A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"Ultragenyx Pharmaceutical Inc","has_results":false},{"nct_id":"NCT05637697","title":"Angelman Syndrome Video Assessment (ASVA) Source Material Study","phase":"","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"The Emmes Company, LLC","has_results":false},{"nct_id":"NCT05630066","title":"A Study to Investigate the Pharmacokinetics (PK) and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT05100810","title":"Angelman Syndrome Natural History Study-FAST UK","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT06115109","title":"Angelman Natural History Study - FAST Spain","phase":"","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Puerta de Hierro University Hospital","has_results":false},{"nct_id":"NCT04863794","title":"A Study To Assess Distribution Of RO7248824 In The Central Nervous System Following Single Intrathecal Doses Of [89zr] Labeled RO7248824 In Healthy Male Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT04103333","title":"Angelman Syndrome (AS) Biomarker Study","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT05011851","title":"An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Neuren Pharmaceuticals Limited","has_results":false},{"nct_id":"NCT03644693","title":"Nutritional Formulation for Angelman Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT07181837","title":"A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"MavriX Bio, LLC","has_results":false},{"nct_id":"NCT03109756","title":"Single Dose Pharmacokinetic (PK) Study","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Healx AI","has_results":false},{"nct_id":"NCT05783791","title":"Development of a Newborn Screening Assay for Angelman Syndrome and Prader-Willi Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"University of Wisconsin, Madison","has_results":false},{"nct_id":"NCT03235037","title":"Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Bennett Lavenstein","has_results":false},{"nct_id":"NCT07136454","title":"Expanded Access/Compassionate Use of Rugonersen in Patients With Angelman Syndrome","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Oak Hill Bio Ltd","has_results":false}],"total":24},"guidelines":[],"source":"Drug Landscape verified database"}